These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2280260)

  • 21. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
    Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
    Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
    [No Abstract]   [Full Text] [Related]  

  • 22. [Analysis and evaluation on quality of live attenuated measles vaccine from market surveillance sampling].
    Fang HH; Wang XX; Yi M
    Zhongguo Yi Miao He Mian Yi; 2009 Dec; 15(6):511-5. PubMed ID: 20518326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further-attenuated measles vaccine: virus passages affect viral surface protein expression, immunogenicity and histopathology pattern in vivo.
    Sinitsyna OA; Khudaverdyan OE; Steinberg LL; Nagieva FG; Lotte VD; Dorofeeva LV; Rozina EE; Boriskin YuS
    Res Virol; 1990; 141(5):517-31. PubMed ID: 2277869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles in Tanzania: antibody response in children after vaccination and antibody state of mothers and newborns.
    de Haas PW; Masurel N; Anker WJ
    Trans R Soc Trop Med Hyg; 1983; 77(2):267-70. PubMed ID: 6868109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low seroconversion rates to measles vaccine among children in Nigeria.
    Adu FD; Akinwolere OA; Tomori O; Uche LN
    Bull World Health Organ; 1992; 70(4):457-60. PubMed ID: 1394778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles immunization with further attenuated heat-stable measles vaccine using five different methods of administration.
    Kok PW; Kenya PR; Ensering H
    Trans R Soc Trop Med Hyg; 1983; 77(2):171-6. PubMed ID: 6868097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Safety and immunogenicity of measles attenuated live vaccine prepared by master seed lot vaccine of Shanghai-191 strain].
    Zhang SJ; Xiao QY; Li FJ
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):423-5. PubMed ID: 20084967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies.
    van Binnendijk RS; Poelen MC; van Amerongen G; de Vries P; Osterhaus AD
    J Infect Dis; 1997 Mar; 175(3):524-32. PubMed ID: 9041322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect in vitro passages on biological properties of attenuated strains of measles virus. II. Immunogenic activity].
    Lityńska J
    Med Dosw Mikrobiol; 1979; 31(2):121-32. PubMed ID: 502644
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
    Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
    J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological characterization of clones derived from the Edmonston strain of measles virus in comparison with Schwarz and CAM-70 vaccine strains.
    Borges MB; Mann GF; Freire Mda S
    Mem Inst Oswaldo Cruz; 1996; 91(4):507-13. PubMed ID: 9070412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant Measles AIK-C Vaccine Strain Expressing the prM-E Antigen of Japanese Encephalitis Virus.
    Higuchi A; Toriniwa H; Komiya T; Nakayama T
    PLoS One; 2016; 11(3):e0150213. PubMed ID: 26930411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.
    Stittelaar KJ; Boes J; Kersten GF; Spiekstra A; Mulder PG; de Vries P; Roholl PJ; Dalsgaard K; van den Dobbelsteen G; van Alphen L; Osterhaus AD
    Vaccine; 2000 May; 18(23):2482-93. PubMed ID: 10775782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
    Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
    Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic characteristics of clones derived from measles virus strain L-16.
    Shteinberg LS; Gordienko NM
    Acta Virol; 1977 Sep; 21(5):383-90. PubMed ID: 22232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chorioallantoic membrane measles: development and clinical evaluation of a new further attenuated measles vaccine.
    Cerini CP; Arguedas J; Hernandez G; Frickey P; Douglas AV
    Appl Microbiol; 1974 Apr; 27(4):763-6. PubMed ID: 4856949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response.
    Sabin AB; Flores Arechiga A; Fernández de Castro J; Albrecht P; Sever JL; Shekarchi I
    JAMA; 1984 May; 251(18):2363-71. PubMed ID: 6368888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.